Olympus Corp. Hits Day High with 7.51% Surge Amid Market Decline

Olympus Corp., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant uptick in its stock performance today, gaining 7.51% as of May 19, 2026. The stock reached an intraday high of JPY 1,878.00, marking a notable achievement amid a challenging market backdrop, as the Japan Nikkei 225 index declined by 0.44% on the same day. Over the past week, Olympus Corp. has shown a robust performance, with a 21.71% increase, contrasting sharply with the Nikkei's 3.49% drop. The company's one-month performance also reflects strength, up 18.41%, while its year-to-date performance stands at a decline of 5.52%. Despite the recent gains, Olympus Corp. has faced challenges over the longer term, with a one-year performance of -0.53% and a three-year decline of 17.91%. The company's market capitalization is currently JPY 1,710,178 million, with a price-to-earnings ratio of 18.00. The debt-equity ratio is notably high at 5.31%, indicating a significant leverage position. Overall, while Olympus Corp. has shown positive movement today, its historical performance suggests a complex financial landscape.